Cancer Diagnostics Market is Estimated to grow by 7.5% CAGR with Industry Insight and Industry Players like ABBOTT, QIAGEN, F. HOFFMANN-LA ROCHE, SIEMENS HEALTHCARE GMBH, THERMO FISHER SCIENTIFIC, GE HEALTHCARE, HOLOGIC | Global Industry Forecast till 202

Cancer Diagnostics Market Highlights
The global cancer diagnostics market is estimated to grow at a CAGR of 7.5% during the forecast period (2018 - 2023). Cancer has become one of the major causes of death across the globe, with the prevalence increasing every year. As a result, healthcare professionals are concentrating on the development of diagnostic and treatment solutions, to check the prevalence level of disease. Early detection of disease increases the success rate of treatment.

Get your sample report now @ https://marketprognosis.com/sample-request/16803
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Increasing Ease of Cancer Diagnosis
Ease of cancer diagnosis has increased substantially over the past decade and is expected to increase further in the coming years. Currently, it is possible to diagnose different cancers, such as breast cancer and prostate cancer, with a simple blood test. The most widely accepted blood tests for breast cancer include BRCA1 and BRCA2. Similarly, conventional imaging technologies have also experienced considerable innovation in the recent past, and breast tomosynthesis is the best example. Breast tomosynthesis is less-painful and way more efficient than conventional mammography. More than 95% of the currently available cancer diagnostics require very minimal intervention and are capable of providing results with very high sensitivity and specificity. Due to this need of minimal intervention, patient compliance has increased in the recent years, which, in turn, has resulted in an increased number of tests, ultimately driving the market growth.
Other factors, such as increasing healthcare expenditure and the emergence of new technologies, like biomarkers and point of care testing, is increasing the growth of the cancer diagnostics market.

Key Developments in the Market
October 2017: Abbott acquired Alere Inc.

Major Players:
ABBOTT, QIAGEN, F. HOFFMANN-LA ROCHE LTD, SIEMENS HEALTHCARE GMBH, THERMO FISHER SCIENTIFIC INC., GE HEALTHCARE, HOLOGIC INC., ILLUMINA INC., PHILIPS HEALTHCARE, AND AGILENT TECHNOLOGIES INC, amongst others

Get Discount on this report @ https://marketprognosis.com/discount-request/16803
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Limited Use in Emerging Markets
The emerging markets have the smallest market share in the overall cancer diagnostics market across the world, because of many region-specific factors. Limitations in the healthcare sector, in most emerging markets, are the reason behind the lack of universal health coverage. Most people cannot afford medical checkups that involve high expenditure, such as cancer diagnostics; lack of universal health coverage is worsening the situation. Along with this, most healthcare facilities in the region are not equipped to perform such high-quality tests. Other than this, the majority of the population in these markets lives in rural areas, with little or no access to even the basic healthcare facilities. Lack of disease awareness is also a major problem in the emerging markets, due to which, most of the population is diagnosed with cancer at a very late stage. These limitations are not only bound to blood tests, but also apply to that diagnosis, which uses imaging equipment and sampling devices. All these limitations are hindering the market growth. The other factor, where expensive diagnostic procedures and market being controlled by few players, are hindering the market growth of cancer diagnostics.

Asia-Pacific to Show the Fastest Growth Rate
North America is dominating the cancer diagnostics market, due to the presence of many biotechnology companies, as well as many medical device manufactures in the region. Asia-Pacific is expected to record a substantial growth over the forecast period, due to the existence of a large patient pool, availability of skilled professionals at a reasonable cost, and a distinct regulatory framework supporting accelerated product approvals.

For More Information, Please Visit @ https://marketprognosis.com/enquiry/16803
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.